Elecsys CA 15-3 II 07027001190Recalls & reported problems
Roche Diagnostics GmbH · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04015630939961), received between Mar 17, 2023 and Mar 17, 2023 — classified as 1 malfunction.
The most frequently reported specific device problem is “High Test Results” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- High Test Results1
- Mechanical Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 17, 2023Mechanical Problem; High Test Results; Mechanical Problem; High Test Results
THERE WAS AN ALLEGATION OF QUESTIONABLE HIGH RESULTS FOR MULTIPLE ASSAYS FOR ONE PATIENT FROM COBAS E 801 ANALYTICAL UNIT SERIAL NUMBER (B)(4). THE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY AND THE DOCTOR BELIEVED THE RESULTS DID NOT MATCH THE MEDICAL IMAGING RESULTS AND QUESTIONED IF THERE WERE INTERFERING SUBSTANCES. REFER TO THE ATTACHMENT TO THE MEDWATCH FOR ALL PATIENT DATA. REFER TO THE MEDWATCHES WITH THE FOLLOWING A1 PATIENT IDENTIFIERS FOR ALL INVOLVED ASSAYS: (B)(6) FOR THE CA 15-3 ASSAY. (B)(6) FOR THE CEA ASSAY. (B)(6) FOR THE CYFRA 21-1 ASSAY. (B)(6) FOR THE CA19-9 ASSAY. (B)(6) FOR THE CA 125 ASSAY. (B)(6) FOR THE AFP ASSAY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16566989 ↗
Other SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR devices
- ADVIA Centaur® CA 15-3® 10327620Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR14 reports
- Atellica IM BR 10995478Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR11 reports
- IMMULITE® 2000 Systems BRM BR-MA (CA15-3) 10380983Siemens Healthcare Diagnostics Products Ltd · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR9 reports
- Atellica IM BR 10995477Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR8 reports
- ADVIA Centaur® BR +G 10333349Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR6 reports
- ADVIA Centaur® BR +G 10334837Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR4 reports
- Dimension Vista® Flex® reagent cartridge CA15-3 10464344Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR4 reports
- Atellica IM CA 15-3 10995485Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page